Skip to main content

Table 3 Upper limb function of all patients who underwent major breast surgery

From: Measuring upper limb function and patient reported outcomes after major breast cancer surgery: a pilot study in an Asian cohort

 

Total (n = 44)

ALND (n = 15)

No ALND (n = 29)

Baseline

Post-operative week 2

Post-operative week 6

p-value*

Baseline

Post-operative week 2

Post-operative week 6

p-value*

Baseline

Post-operative week 2

Post-operative week 6

p-value*

Shoulder flexion AROM+(°)

160 (150–170)

155 (150–165)

160 (146–170)

0.775

165 (150–170)

159 (153–170)

160 (145–170)

0.551

158 (148–166)

155 (149–160)

160 (148–170)

0.319

Shoulder abduction AROM+(°)

157 (150–171)

159 (143–169)

175 (155–180)

0.016

160 (152–173)

165 (146–171)

175 (170–180)

0.443

154 (147–165)

159 (143–165)

172 (155–180)

0.014

Pain score+#

1 (1–1)

1 (1–2)

1 (1–2)

0.054

1 (1–1)

2 (1–2)

1 (1–2)

0.102

1 (1–1)

1 (1–2)

1 (1–2)

0.198

Numbness score+#

1 (1–1)

1 (1–2)

1 (1–2)

0.072

1 (1–1)

2 (1–2)

2 (1–2)

0.166

1 (1–1)

1 (1–2)

1 (1–2)

0.248

QuickDASH disability score+

0 (0–4.03)

6.82 (2.27–13.64)

2.5 (0–8.52)

0.027

2.27 (0–2.5)

6.82 (2.27–15)

5.0 (2.27–9.09)

0.010

0 (0–5.0)

6.82 (2.27–13.64)

2.27 (0–6.82)

0.396

  1. ALND Axillary lymph node dissection, AROM Active range of motion
  2. +All of the study variables in this table are presented in median (IQR) unless otherwise specified
  3. *p-value is obtained by performing a Wilcoxon-signed rank test comparing baseline and post-operative week 6 values
  4. #Pain score and numbness score are components of the QuickDASH questionnaire ranging from 1 to 5, where 1 represents none, 2 represents mild, 3 represents moderate, 4 represents severe and 5 represents extreme
Back to article page

BMC Surgery

ISSN: 1471-2482

Contact us